chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pt recvd vax 16APR93 according to mom; pt had a fever since day of shot; lt thigh site of DTP#2 swollen, w/firm, knotty tissue palpated; parents returned to clinic 22APR93; pt eating, sleeping & weight bearing w/o difficulty;
after recv vax pt devel very swollen leg, hard, sore for one wk. m.d. office visit on 5/24. It was reported that a 2-month-old male received DTAP-TRIPEDIA, IPV-IPOL, COMVAX and ROTA SHEILD vaccines on May 17, 1999. Reportedly on May 20,1999, the patient's right leg became very swollen, hard and sore for one week. The patient had an office visit on May 24,1999, to check reaction. The patient reportedly recovered from this experience. No additional information was received from follow-up correspondence returned to PMC USA on June 14,1999.
About 5:30 or so and I was going to go to lunch at work - I felt like a heartburn and I was looking for a tums. I didn't have any. I asked a coworker because my chest felt like I had heartburn. It was really bad. Protonic - a coworker gave it to me to see if that would help. And I took it. Diaphoretic - sweating - coworker noticed that I was sweating. I had pain in my jaw. I thought I was showing signs of a heart attack. A doctor came over and we told her what was happening with me. He recommended that I should be seen right away. Next thing I know, nurse is wheeling me down to ER in wheelchair as my chest pains weren't going away but ER told me I had to go through triage and wait. Finally got seen and I had an EKG - which was good. CDU unit - was admitted to and checked Troponin levels and did blood work.  Everything came back fine. My EKG was being monitored all night. At one point I was feeling something and they gave me a dose of Nitro. It gave me a headache. There all night and then I did a stress test in the morning. And I was released that day. That was my day off so I was off all work. I went back to the work the day after. My granddaughter came to stay with me over Christmas and she started having symptoms of COVID.  She wasn't feeling well. /She tested positive.Symptoms for COVID began for me on December 26th and was tested for COVID on December 27th - cough; sore throat; headache, fever, not got chills or lose my taste or smell (until after those symptoms were finished); belching - lots; diarrhea; upset; nausea. Extremely tired and muscles aches, joint pain - settled in my lower back and my hip. I still struggle with those joint pain and tiredness today. They put me off work until January 12 2021. I was scheduled to get the dose 2 at 9th but didn't get it that day because of COVID illness.
Approximately 10 minutes after leaving the vaccination site (I felt completely fine while there), I began to feel a slight tightening in my throat (like a lump) and some slight swelling on the lower right side of my face, as well as some nausea.  The symptoms did not worsen and after about 40 minutes, they disappeared.
FLU-LIKE SYMPTOMS; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On 08-APR-2021, the subject experienced flu-like symptoms. Treatment medications on 08-APR-2021 included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from flu-like symptoms. This report was non-serious.
Systemic: Confusion-Severe, Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Severe, Systemic: Vomiting-Severe, Additional Details: patient was having severe vertigo.  He could not walk or open his eyes the vertigo was so bad.  He was sent to the ER and assessed for stroke.  Underwent MRI, CT scan and EKG and all was clear.  The doctor seems fairly certain symptoms were attributed to getting the vaccine.  Started 18 hours after getting the vaccine and is being released from the hospital today.  Still having difficulty walking
Mom reports that she broke out in spots on her bottom and face. They appeared to be blisters with fluid in them. They are almost gone now.
pt received vaccine at 0945, sx onset of arm soreness, weak and dizzy at 1100.  In ED at 1400.
PATIENT HAD STATED THAT  SHE HAD RECEIVED MODERNA AS A FIRST DOSE AND WAS DUE FOR THE SECOND DOSE, PATIENT COULD NOT FIND HER VACCINATION CARD, MODERNA VACCINE SECOND DOSE WAS ADMINISTERED, LATER THE CARD WAS FOUND AND IT INDICATED THAT SHE HAD RECEIVED PFIZER AS A FIRST DOSE, CDC WAS CONTACTED AND AS PER THEIR RECOMMENDATION NO OTHER DOSE WAS NEEDED, PATIENT WAS OBSERVED FOR THE TIME REQUIRED AND DID NOT HAVE ANY ADVERSE EVENT AFTER ADMINISTRATION OF THE VACCINE. PATIENT IS TO CONTACT CDC REGARDING FUTURE RECOMENDATION  FOR ANY FURTHER REQUIRED DOSES.
did not feel good; she was tired; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (did not feel good) and FATIGUE (she was tired) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (did not feel good) and FATIGUE (she was tired). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) at an unspecified dose and frequency. At the time of the report, FEELING ABNORMAL (did not feel good) and FATIGUE (she was tired) outcome was unknown.            Concomitant medication included thyroid medication.   This case was linked to MOD-2021-404069, MOD-2021-404024 (Patient Link).
Inormation has been received concerning a pt who on 09/15/99 was vaccinated with varicella vaccine. On 6/02/00 the pt experienced a breakthrough varicella rash of 20 to 40 lesions. The pt was seen by a physician on 06/01/00. the pt recovered with no further adverse events.
No additional AE/PQC reported; expired VAQTA was administered to a patient; This spontaneous report was received from a medical assistant and referred to a 66-year-old male patient. The patient's medical history, concurrent conditions, concomitant therapies and drug reaction/allergies were not reported.   On 16-JAN-2023, the expired hepatitis a vaccine, inactivated (VAQTA) intramuscular injection was administered to the patient for prophylaxis (lot #U021561, expiration date: 14-JAN-2023; strength, dose and route of administration were not provided) (expired product administered). No additional adverse event (AE) was reported.
all of October I had the H1N1 flu; This case was reported by a consumer via interactive digital media and described the occurrence of h1n1 influenza in a female patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent 2020-2021 season) for prophylaxis.   Co-suspect products included PNEUMOCOCCAL VACCINE (PNEUMONIA VACCINE) for prophylaxis.   On an unknown date, the patient received Influenza vaccine Quadrivalent 2020-2021 season and PNEUMONIA VACCINE. In October 2020, 1 week after receiving Influenza vaccine Quadrivalent 2020-2021 season, the patient experienced h1n1 influenza. The patient was treated with oseltamivir phosphate (Tamiflu). On an unknown date, the outcome of the h1n1 influenza was recovered/resolved.   It was unknown if the reporter considered the h1n1 influenza to be related to Influenza vaccine Quadrivalent 2020-2021 season.  Additional details were provided as follows: The age at vaccination was not reported. A week after vaccination, the patient had the H1N1 flu for all October 2020. It wasn't COVID 19 but it was bad enough. The patient had prescription of Tamiflu. No further information was provided.
Patient c/o light headed. sitting b/p 150/90 pulse 90 laying b/p146/84 pulse 99   monitored  before released b/p 140/80 pulse 88  no s/s of distress   Informed to seed medical attention if any further problems
PT WAS FINE ON DAY 1. SLIGHTLY SORE ON DAY 2, SORER ON DAY 3, ON DAY 4 SHOULDER AREA WAS HOT TO TOUCH, RED AND SLIGHTLY SWOLLEN.
minor soreness; fatigue; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single and (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN (non-serious), outcome "unknown", described as "minor soreness"; FATIGUE (non-serious), outcome "unknown", described as "fatigue".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient present to COVID vaccine clinic for first dose of Moderna. At 2:10 pm patient complained she could not breath and that her throat felt like it was closing up. Oxygen saturation 89% on room air and pulse was 118. RN placed patient on oxygen per protocol. 911 was dialed by LVN. LVN was assisting RN with patient. Notified RN supervisor and was onsite.. Epi pen was administered at 2:12 pm per protocol. 2nd dose of epi was administered 2:18 pm. EMS arrived at 2:25 pm and transported patient to ER. Pt ED/DC 10/18/2021 11:18:00 PM.
Sore arm at injection site immediately after and still after 24 hours post-injection.   Overall feeling of malaise, fatigue, slight chills,  body aches, joint pain from about 8 hours post-vaccination continuing  to 24 hours post-vaccination.  Slight cough and chest congestion, feel warm but no fever (36.6 C).
The day after getting yellow fever vaccine pt began having redness and warmth at injection site. Measures 45x32mm, today no other symptoms reported.
Missed dose; COVID19 infection after 1st dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a health care professional and describes the occurrence of COVID-19 (COVID19 infection after 1st dose) and PRODUCT DOSE OMISSION ISSUE (Missed dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In July 2021, the patient experienced COVID-19 (COVID19 infection after 1st dose). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed dose). At the time of the report, COVID-19 (COVID19 infection after 1st dose) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (Missed dose) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In July 2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were reported. No Treatment information was reported. This spontaneous case concerns a patient of unknown age and gender with no relevant medical history reported, who experienced non-serious unexpected event of special interest (AESI) COVID-19.. The event occurred approximatelly 2 months after the first dose of the Moderna COVID-19 Vaccine (mRNA-1273). Rechallenge was not applicable since due to nature of the event and considering that the patient did not receive the second dose in a recommended timeframe, no rechallenge was done and thus, recurrence was not applicable.  The benefit-risk relationship of drug is not affected by this report.; Sender's Comments: This spontaneous case concerns a patient of unknown age and gender with no relevant medical history reported, who experienced non-serious unexpected event of special interest (AESI) COVID-19.. The event occurred approximatelly 2 months after the first dose of the Moderna COVID-19 Vaccine (mRNA-1273). Rechallenge was not applicable since due to nature of the event and considering that the patient did not receive the second dose in a recommended timeframe, no rechallenge was done and thus, recurrence was not applicable.  The benefit-risk relationship of drug is not affected by this report.
Headaches, pain back of head and ears, numbness / swollen of lips and tongue, fever ,faints, dizziness. Still have headaches
When I received my first dose  and second dose of the Moderna  Covid vaccine I experienced the feeling of contrast solution going through my body. I had a weird taste in my mouth and a weird smell and a warm tingling sensation all over my body that started 30-60 seconds after the vaccine and lasted roughly 15 minutes. I also had slight swelling under my right side of my tongue. I notified the vaccine emergency employee and was told that is weird but that none of my symptoms had ever been reported and there was nothing they could do.
patient was ill; Based on information previously received on 16-Oct-2020, the following information [non-case classification deleted from general tab] has amended.  Initial information was received on 16-Oct-2020 regarding an unsolicited valid non-serious case received from a consumer or non health care professional.  This case involves a patient (unknown age and gender) who had ill, while he/she received vaccine INFLUENZA VACCINE. Patient stated that at least she should be able to tell if she got COVID-19.  Medical history, concomitant therapy, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed non-serious ill (Unknown latency) following the administration of INFLUENZA VACCINE.  Case Detail: Product name was not provided, since this is a public post on the Sanofi flu shot campaign The Race for 200M it was assumed that the consumer is referring to the Sanofi flu vaccine.  Details of laboratory data were not reported.  It was not reported if the patient received any corrective treatment.  At the time of reporting, outcome of the event was unknown.  There will be no information available on batch number for this case.
Within 5 minutes nausea and tightness of chest started.  The nurse gave me Zofran for nausea.  After 30 minutes I seemed to be fine.  On the way home i started severe coughing and bronchial spasm.  I went home and took benadryl which stopped it.  I took another dose that night.  I was fine until 3/17/2021 within minutes of arriving at work I started severe cough, tightness of chest and wheezing.  I took cetirizine.  After 45 minutes cough stopped.  I continued to take cetirizine for 2 weeks and a very old prescription of Singulair.  I had not had any severe allergy symptoms for 11 years.  I was back on all foods except 2.  During this 2 weeks I had to go back off all know allergy foods.  After the 2 weeks
Exposure to covid on Sunday (not aware of this at the time of the flu shot)  Had a cold illness or something on Monday Flu shot on Thursday On Friday I woke up with a headache, achy, and felt feverish. Got a covid test which was negative. Felt sick all day, then fine by midmorning the next morning.
Severe pain upper left arm 12-03 to 12-07-2012 cannot lie on (L) arm or apply pressure. Severe pain has subsided to constant soreness like a bad bruise - certain movements increase pain.
No adverse event; Patient was administered 0.25 ml of Moderna Bivalent booster vaccine instead of 0.5 ml; This spontaneous case was reported by a nurse and describes the occurrence of ACCIDENTAL UNDERDOSE (Patient was administered 0.25 ml of Moderna Bivalent booster vaccine instead of 0.5 ml) and NO ADVERSE EVENT (No adverse event) in a 64-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 030G22B) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .25 milliliter. On 11-Oct-2022, the patient experienced ACCIDENTAL UNDERDOSE (Patient was administered 0.25 ml of Moderna Bivalent booster vaccine instead of 0.5 ml). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (Patient was administered 0.25 ml of Moderna Bivalent booster vaccine instead of 0.5 ml) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (Patient was administered 0.25 ml of Moderna Bivalent booster vaccine instead of 0.5 ml).    No concomitant medication information was provided.  Patient received Moderna bivalent booster dose.  No treatment medication were provided.
Recipient came in on 3/4/2021 to vaccination clinic to receive 2nd dose of Moderna COVID19 vaccine. Recipient stated that after receiving 1st dose, she had within 15 minutes felt tingling in arm that went up to her throat. Felt tingling sensation in her throat in addition to started to have a slight cough and slight shortness of breath. She did not alert the observation team staff and left the clinic.
This spontaneous report was received 65-year-old female patient, who was reporting on herself. The patient's concurrent conditions included paroxysmal arterial fib ration (paroxysmal afib), primordial ulcer, fibromyalgia. She was allergic to AUGMENTIN and VIACIN which made her sick and caused vomiting (date was not provided). On 23-NOV-2009, the patient was vaccinated with ZOSTAVAX, one injection for prophylaxis (lot# and expiration date were not reported). It was uncertain, if ZOSTAVAX injection was administered subcutaneously or intramuscularly. Other suspect therapies included STERILE DILUENT (dose, route of administration, lot# and expiration date were not reported). Concomitant therapies included SOTALOL. On an unknown date, after taking ZOSTAVAX, the patient experienced diarrhea. No laboratory test was performed. The patient did not receive any treatment for the reported event. The outcome of the event was unknown. The relatedness between the events and ZOSTAVAX was not provided.
2-inch red rash around injection site, irregular shaped circle, not painful, slightly raised, warm to the touch, appeared 8 days after first dose of Moderna COVID-19 vaccine. Pregnant on day of vaccine but pregnancy was not known until the afternoon of the shot (injected in the morning), turned out to be chemical pregnancy a few days later.
NAUSEATED, SEVERE BODY PAINS, WAS UNABLE TO LIFT ARMS, RIGHT ARM SWOLLEN
Received injection Sunday afternoon.  Early Monday morning (2/4/2019), head started itching badly.  Wednesday (2/6/2019), hair started falling out in clumps.  By the following Wednesday (2/13/2019) most of my hair had fallen out.  Within a couple of weeks, I had no hair anywhere on my body. Still 5 months later still have no hair anywhere and none looks as if it is growing back.
Severe headache, shortness of breath, fever, body aches starting I believe next day after administration.  Patient also recently started having diarrhea.  Still no outcome or treatment at this time
Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare providers recommended and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. In 2009, a healthcare provider administered the ZOSTAVAX to the patient (lot number, dosage and route of administration not provided). In 2016, the patient was treated by a healthcare provider for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was considered to be not recovered. Additional information has been requested.
Red raised area that is approximately 5 inches long  by three inches wide.  Itchy.  From what I can tell they call it a Covid arm.  It has been 9 days since I received the vaccine.  I was concerned because of my allergies to insect bites being severe.  My arm hurt quite a bit following the injection and I had swelling, but the red raised area looks like a giant ameba. From my research they said the Covid arm usually resolves after the first 24 hours, but this has just started.  I don't want to get the second vaccine.
received the Moderna Monovalent Booster instead of the bivalent vaccine; No adverse event; This spontaneous case was reported by a nurse and describes the occurrence of INCORRECT DOSE ADMINISTERED (received the Moderna Monovalent Booster instead of the bivalent vaccine) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 064A22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INCORRECT DOSE ADMINISTERED (received the Moderna Monovalent Booster instead of the bivalent vaccine) and NO ADVERSE EVENT (No adverse event). At the time of the report, INCORRECT DOSE ADMINISTERED (received the Moderna Monovalent Booster instead of the bivalent vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown.         Concomitant product use was not provided by the reporter.  The nurse stated that it happened because of the monovalent vaccine with the purple border was labeled booster doses.  Treatment information was not provided.
Myalgia, Angioedema, fatigue Narrative:  tenderness and swelling at injection site, fatigue for one day
9/1 Client called to report extreme vertigo, sweating, nausea, feels cold, clammy and tingling in hands. Advised client to see PCP. Stated had taken promethazine and nausea was somewhat better. Spoke w/ client later that day-was at E.R. 9/2 Spoke w/ client. Treated w/ Rx for promethazine and ANTIVERT. Feels better. 9/3 Spoke w/ client. Sx resolving.
Sharp pain in left armpit. Occurred about a day or so after the vaccination. Has not worsened or gotten better.  Stiff swelling near vaccination site. Much more stiff than first dose but is going down a couple days after vaccination.